INBS: Rapid, non-invasive fingerprint drug testing drives growth and margin gains in a $31B market
Delivers rapid, non-invasive fingerprint drug testing with a 16–24 hour detection window, targeting workplace and public sector markets. Achieved strong revenue growth, expanded global customer base, and improved margins through manufacturing efficiencies and IP development.Original document: Intel…